Patient Resources Things You May
Want to Know

Delicious Meals

A Collection of Recipes
Compliments of Takeda

Recipes from The Quiet Gut Cookbook with step-by-step directions and short videos.

Talk with your doctor before making any dietary changes.

Learn More

Get a Free Copy of
The Quiet Gut Cookbook

The Quiet Gut Cookbook

A collection of 135 easy-to-follow and health conscious recipes with detailed food lists, pictures, and guidelines.

Request One Now!

Traveling can be exciting, but if you live with moderate to severe ulcerative colitis (UC) or Crohn's disease (CD), then it may require some additional planning. If you plan on being away from home at the time of your next infusion, use the steps below to prepare accordingly.

Traveling Within the United States

  1. Please notify your healthcare provider of your travel as soon as possible.
  2. If you have US-based health insurance, then work with your healthcare provider for a referral to an infusion center, or contact Entyvio Connect at 1-855-ENTYVIO (1-855-368-9846), which can help you locate an infusion center where you are traveling.
    Your case manager team will also verify if the new infusion center is covered by your plan, and then help you understand your out-of-pocket costs and financial responsibility. If you do not have US-based health insurance, then you may be responsible for paying for treatment in your destination.
  3. It is recommended to have your healthcare provider give you a written plan of action in case of an emergency.

Traveling Outside the United States

  1. Please notify your healthcare provider of your travel as soon as possible.
  2. If you have US-based health insurance, call your case manager team at 1-855-ENTYVIO (1-855-368-9846) and ask if ENTYVIO is approved for use in your destination country. Entyvio Connect will call your insurance provider to determine your coverage and restrictions while abroad. Your case manager team will notify you of the results. If ENTYVIO is not available in your travel destination, Takeda and Entyvio Connect cannot help at this time. Ask your healthcare provider for guidance in this situation and/or consider altering your plans. If you do not have US-based health insurance, then you may be responsible for paying for treatment in your destination.
  3. Work with your healthcare provider and insurance company to identify an infusion center. Entyvio Connect will not be able to locate an infusion center outside the United States.
  4. It is recommended to have your healthcare provider give you a written plan of action in case of an emergency.

A Community of Support

You may find it helpful to reach out to others for support. Use the following resource to find support groups online and in your area, and get more information about ulcerative colitis (UC) and Crohn's disease (CD):

Crohn's & Colitis Foundation of America logo

The Crohn's & Colitis Foundation of America (CCFA) is a non-profit, volunteer-driven organization. You can register with CCFA to find local support groups, education programs and fundraising events in your area.

Learn More

Important Safety Information about ENTYVIO® (vedolizumab)

  • Do not receive ENTYVIO if you have had an allergic reaction to ENTYVIO or any of its ingredients.
  • ENTYVIO may cause serious side effects, including:
    • Infusion and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You may need treatment if you have an allergic reaction. Tell your healthcare provider or get immediate medical help if you get any of these symptoms during or after an infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat or face, shortness of breath or trouble breathing, wheezing, dizziness, feeling hot, or palpitations (feel like your heart is racing).
    • ENTYVIO may increase your risk of getting a serious infection. Before receiving and during treatment with ENTYVIO, tell your healthcare provider if you think you have an infection or symptoms of an infection, such as fever, chills, muscle aches, cough, shortness of breath, runny nose, sore throat, red or painful skin or sores on your body, tiredness, or pain during urination.
    • Although it has not been reported with ENTYVIO, it may be possible for a person to get progressive multifocal leukoencephalopathy (PML) (a rare, serious brain infection caused by a virus). People with weakened immune systems can get PML, which can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any of the following symptoms: confusion or problems thinking, loss of balance, change in the way you walk or talk, decreased strength or weakness on one side of the body, blurred vision, or loss of vision.
    • Liver problems can happen in people who receive ENTYVIO. Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
  • The most common side effects of ENTYVIO include common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, and pain in extremities. These are not all the possible side effects of ENTYVIO. Call your healthcare provider for medical advice about side effects.
  • Before receiving ENTYVIO, tell your healthcare provider about all of your medical conditions, including if you: have or think you may have an infection or have infections that keep coming back; have liver problems; have tuberculosis (TB) or have been in close contact with someone with TB; have recently received or are scheduled to receive a vaccine; or if you are pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Uses of ENTYVIO® (vedolizumab)

ENTYVIO is a prescription medicine used in adults:

  • with moderate to severe ulcerative colitis (UC) when certain other UC medicines have not worked well enough or cannot be tolerated. ENTYVIO may help to: begin reducing some symptoms, induce and maintain remission, reduce or stop the use of corticosteroids, and improve the way the lining of your large intestine looks to your healthcare provider.
  • with moderate to severe Crohn's disease (CD) when certain other CD medicines have not worked well enough or cannot be tolerated. ENTYVIO may help to: begin reducing some symptoms, achieve remission, and reduce or stop the use of corticosteroids.

Please see the Full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.

Important Safety Information about ENTYVIO® (vedolizumab)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Uses of ENTYVIO® (vedolizumab)

ENTYVIO is a prescription medicine used in adults:

Please see the Full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider.